Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-28
2005-06-28
Badio, Barbara P. (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S207000
Reexamination Certificate
active
06911441
ABSTRACT:
Novel pharmaceutical compositions of a cephalosporin in a prolonged release vehicle, comprising an oil and aluminium distearate, provide a prolonged duration of effective blood-plasma concentration of the cephalosporin after injection to animals.
REFERENCES:
patent: 3920819 (1975-11-01), Stephens et al.
patent: 4258041 (1981-03-01), O'Callaghan et al.
patent: 4341777 (1982-07-01), White
patent: 5013833 (1991-05-01), Crisp et al.
patent: 792545 (1956-07-01), None
patent: 2 087 236 (1981-11-01), None
patent: WO 87/03876 (1987-07-01), None
patent: WO 00/61149 (2000-10-01), None
patent: WO 03/063877 (2003-08-01), None
XP-002240092, JP 19850075377, 1985.
Allan Mark
Barbot Carole
Boettner Alexander
Schmid Peter
Schmidt Carsten
Akzo Nobel N.V.
Badio Barbara P.
Blackstone William M.
LandOfFree
Prolonged release pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolonged release pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolonged release pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3488211